Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SUVEN | NSE
-1.33
-0.85%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
18/09/2024
155.78
157.65
169.30
154.40
Suven Life Sciences Limited a clinical-stage biopharmaceutical company focuses on the acquisition development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India the United States Europe and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies. Its product candidates include SUVN-502 for the treatment of Alzheimer's disease and neuropsychiatric symptoms; SUVN-G3031 a potent and selective histamine H3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and SUVN-911 a novel potent and selective a4ß2 nicotinic acetylcholine receptor antagonist for the treatment of depressive disorders. The company is also developing SUVN-D4010 a potent selective and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders and schizophrenia; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Weakness based on declining price with high volume
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
56.9%1 month
47.7%3 months
60.1%6 months
52.0%-
-
12.28
0.00
0.00
-11.71
360.65
-
-1.31B
33.97B
406.05M
-
-3.18K
1.56K
-73.50
-32.56
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
32.11
Range1M
33.14
Range3M
74.10
Rel. volume
1.90
Price X volume
168.38M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 143.65 | 36.89B | -1.84% | 14.02 | 0.42% |
RPG Life Sciences Limited | RPGLIFE | Drug Manufacturers-Specialty & Generic | 2174.75 | 36.30B | -2.27% | 43.29 | 0.00% |
Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 370.1 | 34.24B | -1.33% | 46.10 | 60.54% |
SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 742.9 | 32.02B | -0.01% | n/a | 107.90% |
IOL Chemicals and Pharmaceuticals Limited | IOLCP | Drug Manufacturers-Specialty & Generic | 502.2 | 29.49B | 2.02% | 25.17 | 2.03% |
Themis Medicare Limited | THEMISMED | Drug Manufacturers-Specialty & Generic | 258.95 | 23.87B | -5.92% | 49.52 | 25.36% |
Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 804.9 | 23.25B | 3.29% | 53.49 | 0.60% |
Syncom Formulations (India) Limited | SYNCOMF | Drug Manufacturers-Specialty & Generic | 23.18 | 22.16B | -2.85% | 83.97 | 25.16% |
Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 2404.5 | 20.49B | -1.99% | 104.10 | 83.75% |
Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 872.4 | 18.29B | -2.56% | 31.83 | 0.81% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
"SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 183.46 | 27.05B | -1.24% | 29.68 | 43.67% |
Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 31.55 | 27.02B | -4.54% | 82.05 | 10.74% |
Signpost India Limited | SIGNPOST | Advertising Agencies | 229.62 | 23.62B | 0.79% | n/a | 80.30% |
Bhagyanagar India Ltd | BHAGYANGR | Copper | 106.49 | 3.41B | -2.42% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 172.05 | 1.91B | 1.72% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 96.65 | 1.38B | -1.91% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.91 | 1.03B | -1.89% | n/a | 32.70% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.89 | 336.84M | -5.34% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.05 | 303.87M | -0.98% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -11.71 | 23.29 | Cheaper |
Ent. to Revenue | 360.65 | 12.02 | Expensive |
PE Ratio | - | 47.84 | - |
Price to Book | 12.28 | 6.55 | Expensive |
Dividend Yield | - | 0.59 | - |
Std. Deviation (3M) | 60.12 | 40.95 | Riskier |
Debt to Equity | 0.00 | 0.34 | Cheaper |
Debt to Assets | 0.00 | 0.17 | Cheaper |
Market Cap | 33.97B | 286.13B | Emerging |